ASX Announcements

Investor Presentation - ShareCafe

ASX Announcement General iTrack Molteno3 AlphaRET

19 May, 2023

Cleansing Notice

ASX Announcement General iTrack Molteno3 AlphaRET

5 May, 2023

Application for Quotation of Securities

ASX Announcement General iTrack Molteno3 AlphaRET

5 May, 2023

iTrack Advance First Surgeries and Sales in USA

ASX Announcement General iTrack Molteno3 AlphaRET

1 May, 2023

FDA Clears iTrack Advance for US Launch

ASX Announcement General iTrack Molteno3 AlphaRET

31 Mar, 2023

Notice of General Meeting

ASX Announcement General iTrack Molteno3 AlphaRET

28 Mar, 2023

Application for Quotation of Securities

ASX Announcement General iTrack Molteno3 AlphaRET

8 Mar, 2023

Cleansing Notice

ASX Announcement General iTrack Molteno3 AlphaRET

8 Mar, 2023

Reinstatement to Quotation

ASX Announcement General iTrack Molteno3 AlphaRET

2 Mar, 2023

Proposed issue of securities - 2 March 2023

ASX Announcement General iTrack Molteno3 AlphaRET

2 Mar, 2023

Half Yearly Accounts 31 December 2022

ASX Announcement General iTrack Molteno3 AlphaRET

2 Mar, 2023

Investor Presentation Half Year Results 31 Dec 2022

ASX Announcement General iTrack Molteno3 AlphaRET

2 Mar, 2023

Nova Eye Completes $8m Placement

ASX Announcement General iTrack Molteno3 AlphaRET

2 Mar, 2023

Suspension from Official Quotation

ASX Announcement General iTrack Molteno3 AlphaRET

28 Feb, 2023

Trading Halt

ASX Announcement General iTrack Molteno3 AlphaRET

27 Feb, 2023

Additional Clinical Role for 2RT

ASX Announcement AlphaRET

25 Jan, 2023

Status of Market Clearance for iTrack Advance in the USA

ASX Announcement General iTrack Molteno3 AlphaRET

12 Dec, 2022

AGM Presentation 2022

ASX Announcement General iTrack Molteno3 AlphaRET

17 Nov, 2022

Glaucoma Surgical Devices Sales Update

ASX Announcement General iTrack Molteno3 AlphaRET

16 Nov, 2022

AlphaRET Completes Initial Recruitment of Investigator Sites for 2RT® Confirmatory Pivotal Study

ASX Announcement General iTrack AlphaRET

24 Oct, 2022

Notice of Annual General Meeting

ASX Announcement General iTrack Molteno3 AlphaRET

14 Oct, 2022

2RT Presentation Professor Robyn H Guymer Today 15 Sept 2022

ASX Announcement General AlphaRET

15 Sept, 2022

AGM Date and Directors Nominations

ASX Announcement General iTrack Molteno3 AlphaRET

14 Sept, 2022

EYE 2RT Webinar Prof Guymer

ASX Announcement General iTrack Molteno3 AlphaRET

9 Sept, 2022

EYE FY22 Appendix 4G & Governance Statement

ASX Announcement General iTrack Molteno3 AlphaRET

26 Aug, 2022

EYE FY22 Results Presentation

ASX Announcement General iTrack Molteno3 AlphaRET

26 Aug, 2022

EYE FY22 Results Announcement

ASX Announcement General iTrack Molteno3 AlphaRET

26 Aug, 2022

EYE FY22 Appendix 4E & Annual Report

ASX Announcement General iTrack Molteno3 AlphaRET

26 Aug, 2022

Nova Eye Medical Launches iTrack Advance

ASX Announcement General iTrack Molteno3 AlphaRET

8 June, 2022

For investor enquires please contact:

Mark Flynn
Nova Eye Medical Limited
W +61 416 068 733
mflynn@nova-eye.com

This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More